Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSpecial Contribution

Dosimetric Aspects of Radiolabeled Antibodies for Tumor Therapy

John Laurence Humm
Journal of Nuclear Medicine September 1986, 27 (9) 1490-1497;
John Laurence Humm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 9 1490-1497
PubMed 
3528417

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT © 1986 by The Society of Nuclear Medicine, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 261 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2001 to April 2025

AbstractFullPdf
Mar 2001100
Apr 2001100
Mar 2002300
Apr 2002001
Dec 2002400
Jan 2003300
Mar 2003300
Jun 2003100
Jul 2003500
Aug 2003600
Sep 2003300
Oct 2003500
Nov 2003500
Dec 2003400
Jan 2004500
Feb 2004600
Mar 2004300
Apr 2004400
May 2004700
Jun 20041800
Jul 20042200
Aug 2004500
Sep 2004100
Oct 2004700
Nov 2004600
Dec 2004400
Jan 20051000
Feb 2005600
Mar 2005500
Apr 2005100
May 2005700
Jul 2005100
Aug 2005100
Oct 2005100
Nov 2005300
Dec 2005100
Jan 2006100
Feb 2006100
Apr 2006500
May 2006100
Jun 2006100
Jul 2006400
Aug 2006100
Oct 2006300
Nov 2006200
Jan 2007508
Feb 2007302
Mar 2007004
Apr 2007503
May 2007203
Jun 2007404
Jul 20073011
Aug 2007108
Sep 20071011
Oct 2007002
Nov 2007007
Dec 2007308
Jan 2008203
Feb 2008001
Mar 2008005
Apr 2008203
May 2008007
Jun 2008809
Jul 2008104
Aug 20081009
Sep 2008704
Oct 2008407
Nov 20085015
Dec 2008505
Jan 2009102
Feb 20091007
Mar 2009505
Apr 2009103
May 2009607
Jun 2009003
Jul 2009203
Aug 2009205
Sep 2009806
Oct 2009504
Nov 2009608
Dec 2009207
Jan 2010202
Feb 20107010
Mar 2010805
Apr 20109010
May 20105013
Jun 20107016
Jul 20101010
Aug 2010103
Sep 2010506
Oct 2010902
Nov 201013017
Dec 20106011
Jan 20117010
Feb 20116013
Mar 201112015
Apr 201114015
May 2011203
Jun 20110018
Jul 20110016
Aug 20110011
Sep 20110016
Oct 20110019
Nov 20110020
Dec 20110025
Jan 20120015
Feb 20120020
Mar 20120017
Apr 2012003
May 20120021
Jun 20120020
Jul 2012009
Aug 20120012
Sep 2012009
Oct 20120021
Nov 20120010
Dec 2012009
Jan 20130012
Feb 2013009
Mar 2013007
Apr 2013006
May 2013007
Jun 2013009
Jul 2013002
Aug 2013007
Sep 2013003
Oct 2013004
Nov 2013002
Dec 2013005
Jan 2014004
Feb 2014007
Mar 20140013
Apr 20140029
May 20140039
Jun 20140028
Jul 20140016
Aug 2014006
Sep 20140012
Oct 20140027
Nov 2014006
Dec 2014003
Jan 20150014
Feb 20150011
Mar 2015006
Apr 20150010
May 2015008
Jun 2015003
Jul 20150011
Aug 2015003
Sep 2015009
Oct 2015003
Nov 2015005
Dec 2015006
Jan 20160017
Feb 2016008
Mar 2016009
Apr 20160014
May 20160018
Jun 2016005
Jul 20160017
Aug 2016009
Sep 2016005
Oct 20160113
Nov 20160111
Dec 2016003
Jan 20170032
Feb 2017008
Mar 2017006
Apr 20170010
Jun 2017003
Aug 2017007
Sep 2017001
Oct 2017004
Nov 2017008
Dec 2017007
Jan 20180010
Feb 2018001
Mar 2018003
Apr 2018001
May 2018001
Jun 2018006
Jul 2018001
Aug 2018003
Sep 2018003
Oct 2018005
Nov 2018009
Dec 2018002
Jan 2019001
Feb 2019002
Mar 2019002
Apr 2019004
May 2019005
Jun 2019001
Jul 2019003
Aug 2019002
Sep 2019002
Oct 20190052
Nov 20190017
Dec 2019004
Jan 2020003
Feb 2020001
Mar 2020006
Apr 2020007
May 2020001
Jun 2020001
Aug 2020001
Sep 2020004
Oct 2020003
Nov 2020004
Dec 2020003
Jan 2021005
Feb 2021007
Mar 2021004
Apr 2021109
May 2021103
Jun 2021102
Jul 2021104
Aug 2021105
Sep 2021003
Oct 20210013
Nov 20210018
Dec 20210010
Jan 2022005
Feb 2022102
Mar 2022108
Apr 2022005
May 2022002
Jun 20221010
Jul 20220011
Aug 2022007
Sep 2022008
Oct 2022002
Nov 2022005
Dec 2022106
Jan 20233017
Feb 2023007
Mar 20230010
Apr 2023006
May 20230010
Jun 2023007
Jul 2023009
Aug 2023008
Oct 20230017
Nov 20230013
Dec 2023002
Jan 2024005
Feb 2024109
Mar 2024109
Apr 20240013
May 20241018
Jun 20240024
Jul 2024107
Aug 20240010
Sep 2024009
Oct 2024007
Nov 20240014
Dec 20241010
Jan 2025107
Feb 2025207
Mar 20250010
Apr 20251017
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 27, Issue 9
September 1, 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dosimetric Aspects of Radiolabeled Antibodies for Tumor Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dosimetric Aspects of Radiolabeled Antibodies for Tumor Therapy
John Laurence Humm
Journal of Nuclear Medicine Sep 1986, 27 (9) 1490-1497;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dosimetric Aspects of Radiolabeled Antibodies for Tumor Therapy
John Laurence Humm
Journal of Nuclear Medicine Sep 1986, 27 (9) 1490-1497;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Radiation Safety Considerations and Clinical Advantages of {alpha}-Emitting Therapy Radionuclides
  • 124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
  • Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
  • A Pharmacokinetic Model for Radioimmunotherapy Delivered Through Cerebrospinal Fluid for the Treatment of Leptomeningeal Metastases
  • Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease
  • Further Explorations of Cellular Uptake of Radioactivity
  • Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease
  • Targeted {alpha}-Particle Therapy of Microscopic Disease: Providing a Further Rationale for Clinical Investigation
  • Log Normal Distribution of Cellular Uptake of Radioactivity: Implications for Biologic Responses to Radiopharmaceuticals
  • Abbreviated Chemotherapy With Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab for Untreated Follicular Lymphoma
  • Liposome-Mediated Radiotherapeutics Within Avascular Tumor Spheroids: Comparative Dosimetry Study for Various Radionuclides, Liposome Systems, and a Targeting Antibody
  • Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease
  • Impact of Nodal Regression on Radiation Dose for Lymphoma Patients After Radioimmunotherapy
  • Google Scholar

More in this TOC Section

  • Theranostics in Perspective: White Paper
  • Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins
  • Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
Show more Special Contribution

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire